BACKGROUND Mucinous neoplasms within the abdomen may disseminate by direct extension through the diaphragm to involve the pleural space. Treatment of this condition is by parietal and visceral pleurectomy followed by hyperthermic intrapleural chemotherapy. CASE PRESENTATION In this case report a patient developed persistent right upper lobe interstitial pneumonitis and progressive parenchymal...

Primary percutaneous coronary intervention (PCI) is a better reperfusion therapy for ST-segment elevation acute myocardial infarction than in-hospital fibrinolytic therapy when it is performed soon after the onset of symptoms by an experienced team. Both the American and the European guidelines for the management of ST-segment elevation acute myocardial infarction recommend that the procedure s...

BACKGROUND Significant morbidity and mortality result from the ineffective evacuation of empyema. Failure of conventional first line treatment with closed intercostal tube drainage and antibiotic therapy may result in fibrin deposition and loculated empyema. Enzymatic debridement using intrapleural instillation of streptokinase is a non-invasive therapeutic option which may obviate the need for...

Cardiovascular diseases, such as heart attack and stroke, are the leading causes of death in North America. According to data provided by the World Health Organization in 2000, heart diseases are responsible for 29% of the total mortality rate in the world. Since cardiovascular diseases have a major impact on an individual s quality of life, a tremendous amount of research has been done in the ...

Primary percutaneous coronary intervention (PCI) is a better reperfusion therapy for ST-segment elevation acute myocardial infarction than in-hospital fibrinolytic therapy when it is performed soon after the onset of symptoms by an experienced team. Both the American and the European guidelines for the management of ST-segment elevation acute myocardial infarction recommend that the procedure s...

IT HAS been shown in experimental animals that the human fibrinolytic enzyme (plasminogen activated with streptokinase) will dissolve fresh intravascular thrombi." Fibrinolytic agents are also undergoing an extensive clinical trial and the preliminary reports which have appeared*" have suggested that this type of therapy will be of value in the management of thrombo-embolic disorders. Variation...